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Edited by Hans-Dieter KlenkAbstract The ICP0 protein of herpes simplex virus type 1
(HSV-1) is a nuclear protein that possesses a well-characterized
E3 ubiquitin ligase activity. This activity is responsible for the
proteasomal-dependent degradation of several cellular proteins.
This study shows that ICP0 induces the proteasomal-dependent
degradation of the centromeric protein CENP-B in infected as
well as ICP0-expressing cells. It is also shown that the ICP0-in-
duced CENP-B degradation occurs as eﬃciently in human and
mouse cells. CENP-B is one of the major proteins of centromeres
and its degradation is likely to contribute to the severe damage
induced to centromeres by ICP0.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Centromeres are specialized chromosomal regions whose
structure is the support for the building of the kinetochore,
which is the attachment site of spindle microtubules during
meiosis and mitosis. They are made of both speciﬁc AT-rich al-
pha-satellite (or alphoid) tandemDNA repeats and constitutive
proteins present throughout the cell cycle. Human centromeres
are speciﬁed by two regions on the basis of DNA and protein
content, (i) the central core region, which is exclusively formed
by type I alpha-satellite 171-bp repeated DNA associated with
several speciﬁc centromeric proteins (CENPs), (ii) the peri-cen-
tromere which is composed of a mix of type I alpha-satellite
DNA as well as other divergent alphoid sequences associated
with classical histones in a heterochromatic conformation.
One of the major features of the central core centromere, at
the chromatin structure level, is the presence of nucleosomes
containing the histone H3-like protein CENP-A, in addition
to classical histone H3-containing nucleosomes. Moreover,
type I alpha-satellite DNA includes a speciﬁc 17-nt sequence,
called the ‘‘CENP-B box’’, serving as an anchor platform for
the DNA-binding protein CENP-B. CENP-B could be consid-
ered as the historical centromere protein as it was the ﬁrst
described constitutive CENP. Its precise role in the centromere*Corresponding author. Address: Universite´ Lyon 1, Lyon, F-69003,
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doi:10.1016/j.febslet.2007.01.027structure has not yet been determined but some data obtained
in vitro highly suggests that it is implicated in the positioning of
centromeric nucleosomes [1,2].
The herpes simplex virus type 1 (HSV-1) is a common hu-
man pathogen (for a review see [3]). ICP0 is an important nu-
clear protein synthesized during infection by HSV-1 (for
reviews see [4,5]). It contains a RING ﬁnger zinc-binding do-
main, which confers to ICP0 an E3 ubiquitin ligase activity
implicated in the proteasomal degradation of a series of cellu-
lar proteins [4–6]. As soon as ICP0 enters the nucleus it specif-
ically and temporarily localizes in two nuclear domains, i.e.,
the PML bodies (also called ND10), and the centromeres.
Immediately, ICP0 provokes the proteasomal degradation of
the PML protein and of the major centromeric proteins,
CENP-A and -C. The consequences being the disappearance
of the PML bodies, and the destabilization of the centromeres,
provoking mitotic defects [7–10]. In this study we describe, in
human and mouse cells, the ICP0-induced proteasomal degra-
dation of a third CENP, the CENP-B protein.2. Materials and methods
Cell lines, plasmids and viruses. HeLa cells were cultivated in BHK-
21 medium, NIH3T3 in DMEM medium; HeLa T-REX (Invitrogen)
and TREX-ICP0 (TR-ICP0.39) in MEM, all media complemented
with at least 10% fetal calf serum, L-Glutamin (1% v/v), 10 U/ml of
penicillin, 100 lg/ml of streptomycin; for T-REX, blasticidin was
added to the medium (5 lg/ml); for TR-ICP0.39 blasticidin and zeocin
(100 lg/ml) were added. The wild type strain HSV-1 17syn+ (HSV-
1wt) is the parental strain used in this study. The viruses dl1403,
deleted of ICP0 [11], and vFXE, expressing an ICP0 isoform mutated
in its RING ﬁnger domain [12] were also used.
TR-ICP0.39 cell line, stably and inducibly expressing ICP0, was con-
structed by transfecting T-REX cells with a pcDNA 4/TO plasmid
(Invitrogen) designed to express the ICP0 gene. Cell clones were then
isolated under zeocin selection. Expression of ICP0 was induced by
addition of tetracycline (1 lg/ml) to the medium, and checked in sev-
eral clones by Western blotting and immunocytochemistry.
Immunoﬂuorescence. TR-ICP0.39 and NIH3T3 cells were seeded at
2.5 · 105 and 7.5 · 104 cells per well, respectively, in 24 well plates con-
taining a round coverslip prior immunoﬂuorescence (IF) assay. Cells
were treated for IF as described in [9].
Western blotting. HeLa (5 · 105 cells) or NIH3T3 (3 · 105 cells) in
35 mm Petri dish were infected for 6 h at a multiplicity of infection
of 10 (all cells are infected) by the virus HSV-1wt, vFXE or dl1403,
in the presence or not of proteasome inhibitor MG132 (2.5 lM). For
TR-ICP0 cells, cells were seeded at 1 · 106 cells per 60 mm Petri dish
then the following day tetracycline was added or not to the medium
for 24 h. Forty micrograms of total proteins were loaded per well of
a SDS–polyacrylamide gel, before running, transfer and detection as
described in [13].blished by Elsevier B.V. All rights reserved.
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tern blotting (WB) experiments are the following: monoclonal antibod-
ies (mAbs) [11060] anti-ICP0 (1/1000, IF; 1/10000, WB), [3–19] anti-
CENP-A (1 lg/ml, WB; Abacm), [5E6C1] anti-CENP-B (1/1000, IF;
1 lg/ml WB), [5E10] anti-PML (1/50, IF); rabbit polyclonal antibodies
R190 anti-ICP0 (1/200, IF), anti-CENP-A (1/200, IF; Upstate), r554
anti-CENP-C (1/1000, IF and WB), anti-actin (1 lg/ml, WB; Sigma);
a human autoimmune serum huACA against centromeric proteins
was also used (1/3000, IF in human cells; 1/500, IF in mouse cells).
For IF secondary antibodies used were goat anti-rabbit, anti-mouse,
and anti-human coupled to AlexaFluor 488, 555, or 647 (1/200; Molec-
ular probes).3. Results and discussion
In a previous study describing the ICP0 and proteasomal-in-
duced degradation of the centromeric CENP-C protein [7], we
suggested that CENP-B was not destabilized by ICP0 because,
by immunocytochemistry, a CENP-B signal was still present at
the centromeres in ICP0-expressing cells. Because we know
that CENP-A stability is also aﬀected by ICP0 [9], we wanted
to have a clear mind concerning the truthfulness of the existing
stability discrepancy among diﬀerent CENPs with regard to
ICP0 activity. Western blotting was then performed on in-
fected HeLa cells to analyze the CENP-B stability (Fig. 1).
The CENP-B signal greatly diminished in HSV-lwt infected
cells in the absence of the proteasome inhibitor MG132 (com-
pare lanes 3 and 4 in Fig. 1). Moreover infection by the ICP0
mutant viruses, dll403 and vFXE, had no eﬀect on CENP-B
stability. As a positive control, CENP-C was degraded in
HSV-lwt infected cells in the absence of MG132, as previously
shown. This result suggests that unexpectedly, and unlike our
previous suggestion, CENP-B is degraded in infected cells. We
then decided to go further in our investigations.
By immunocytochemistry, the disappearance of CENP-A
and CENP-C signals are clearly visible at a single cell level,
in transfected cells expressing ICP0. However, it has neverFig. 1. The CENP-B signal decreases in human cells infected with
HSV-1wt. HeLa cells were all infected (multiplicity of infection of 10)
with viruses HSV-1wt (in the presence or not of proteasome inhibitor
MG132), dl1403 (ICP0 null), or vFXE (ICP0 mut) for 6 h. Western
blotting was performed for the detection of CENP-B, and -C (arrow),
ICP0, and actin as loading control.been possible to attest by Western blotting the eﬀect of ICP0
on endogenous CENPs stability in transfected cells, because
of the low amount of cells (less than 30%) expressing ICP0
by transfection. To avoid this problem we decided to construct
a cell line stably and, inducibly expressing ICP0 (see Section 2).
One clone named TR-ICP0.39 was selected on the basis of
three criteria: (i) ICP0 expression was null unless tetracycline
was added to the medium, (ii) ICP0 was expressed in 100%
of the cells, (iii) ICP0 expression was low, but enough to confer
its biological activities, especially on the induction of degrada-
tion of cellular proteins. In the absence of tetracycline no ICP0
was detectable by immunoﬂuorescence (data not shown).
Addition of tetracycline set oﬀ the expression of ICP0
(Fig. 2Aii, iv, vi; green labelling). As expected, CENP-A, -C,
and PML signals disappeared in the presence, but not in the
absence, of tetracycline (compare Fig. 2Ai, iii, v and 2Aii, iv,
vi). It was veriﬁed that tetracycline on its own did not aﬀect
the stability of these proteins (data not shown). We then per-
formed Western blotting to detect CENP-A, -B, and -C degra-
dation. In the absence of tetracycline no ICP0 was detectable,
which matched with the observations made by immunoﬂuores-
cence. In these conditions all three centromeric proteins were
easily detectable (Fig. 2B, lane 1). When tetracycline was
added, ICP0 became detectable and, as expected, CENP-A
and -C amounts were signiﬁcantly decreased (Fig. 2B, lane
2). The CENP-B signal also decreased, which supported our
observations made in infected cells about an ICP0-induced
degradation of this protein. The addition of MG132 restored
the corresponding signals in accordance with ICP0 acting
through the ubiquitin-proteasome pathway (Fig. 2B, lane 3).
These results are important for two reasons. Firstly, because
this is the ﬁrst time that we are able to formally show that
ICP0 on its own (outside of an infection) targets endogenous
CENPs for proteasomal degradation. Secondly, because it
highly suggests that CENP-B stability is aﬀected by ICP0, sim-
ilarly to CENP-A and -C.
However it remains true that, using an immunocytochemis-
try approach, the human cells expressing ICP0 (infected, trans-
fected or tetracycline-induced TR-ICP0.39 cells) do not show a
clear disappearance of the CENP-B signal, unlike that of
CENP-A and -C (data not shown, but see Fig. 2C and H in
[7]). The reasons for such a discrepancy might be of two or-
ders. Firstly, for unknown reasons ICP0 could induce
CENP-B degradation less eﬃciently than CENP-A and -C.
Secondly, ICP0 could target CENP-B for proteasomal degra-
dation as eﬃciently as CENP-A and -C, but the diﬀerent
CENP-B localization in the centromere compared to CENP-
A and -C, suggests that part of the pool of CENP-B is not
destabilized by ICP0. Indeed, type I alpha-satellite sequences
containing the ‘‘CENP-B box’’ are part of the central core cen-
tromere but also extend beyond to ﬂanking regions. This sug-
gests that, unlike for CENP-A and -C, the CENP-B
localization on the centromere might be a lot wider then the
region covered by ICP0. According to this, CENP-B was
found, by electron microscopy, to localize also beneath and be-
side the central core centromere region [14]. Our diﬀerent stud-
ies describing centromeric ICP0 localization tend to show a
localization of ICP0 restricted to the central core centromere
and not to the adjacent peri-centromeric regions. If we con-
sider that ICP0 only ubiquitinates eﬃciently proteins being
in its immediate vicinity, it is reasonable to anticipate a partial
degradation of the CENP-B protein present on centromeres.
Fig. 2. CENP-B is degraded in the TR-ICP0.39 cell line. (A) Immunoﬂuorescence study showing the correct ICP0 expression and activity in the TR-
ICP0.39 (TR-ICP0) cell line. In the absence of tetracycline, the CENP-A, -C and PML signals are not aﬀected (i, iii, v). Addition of tetracycline for
24 h induces the expression of ICP0 (ii, iv, vi; green signal), and the disappearance of the CENP-A, -C and PML dots (red signal). Nuclei are shown
by the DAPI staining (blue). Bars represent 5 lm. (B) TR-ICP0.39 cells were induced or not by tetracycline for 24 h, in the presence or not of
proteasome inhibitor MG132. Western blotting was performed for the detection of CENP-A, -B, and -C, ICP0, and actin as loading control.
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peats called minor and major satellite repeats [15]. The minor
satellite units are exclusively part of the central core centro-
mere and the major satellite repeats are exclusive of the peri-
centromeric regions [16]. Another major diﬀerence is that the
‘‘CENP-B box’’ is only present in the minor satellite repeats
[17]. CENP-B is thus likely to exclusively associate with this re-
gion. Therefore, we decided to repeat infection experiments in
mouse cells to verify if the ICP0-induced CENP-B degradation
was more obviously detectable in this species. Infected
NIH3T3 mouse cells were treated for immunoﬂuorescence
using a human autoimmune serum (huACA) recognizing sev-eral human CENPs [18], and also working in mouse cells
[16]. Additionally, a monoclonal antibody (mAb) raised
against human CENP-B, which also recognises mouse cenpB
was used. As expected, in ICP0-expressing cells the centro-
meric signal signiﬁcantly decreased when using the huACA
serum, and more importantly, the cenpB signal completely dis-
appeared when the mAb anti-CENP-B was used (Fig. 3Ai and
ii). Nothing comparable was observed in cells expressing a
non-functional ICP0 protein mutated in its RING ﬁnger do-
main (data not shown). To ﬁnalise this study, NIH3T3 cells
were infected to perform Western blotting to detect mouse
cenpB stability. Human CENP-B is an 80 kDa protein, and gi-
Fig. 3. ICP0 induces the degradation of cenpB in mouse cells. (A) NIH3T3 mouse cells were infected by HSV-1wt for 4 h to perform
immunoﬂuorescence assays, (i) HuACA serum was used to detect centromere proteins (green), (ii) [5E6C1] mAb anti-CENP-B was used to
speciﬁcally detect mouse cenpB (green). Infected cells are detected by the ICP0 positive signal (red). Nuclei are labelled by DAPI staining (blue).
Merge images show the co-localization of green dots (central core centromeres) with DAPI spots (peri-centromeric heterochromatin) in non-infected
cells. Arrows point out infected cells. Bars represent 5 lm. (B) NIH3T3 mouse cells were all infected (multiplicity of infection of 10) by viruses HSV-
1wt (in the presence or not of proteasome inhibitor MG132), dl1403, or vFXE for 6 h prior to performing Western blotting for the detection of cenpB
(80 kDa), ICP0, and actin as loading control. 110 kDa indicates an extra band speciﬁcally detected with the [5E6C1] mAb anti-CENP-B only in
mouse cells.
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human and mouse CENP-B it is expected for mouse cenpB
to possess a similar molecular mass. Looking at the protein
migrating at this size it is clear that cenpB disappeared in
HSV-1wt infected cells in the absence but not in the presence
of MG132 (Fig. 3B, compare lanes 2 and 3). In samples com-
ing from mutant virus-infected cells, cenpB was still detectable
(Fig. 3B, lanes 4 and 5). These data undoubtedly conﬁrm the
ICP0- and proteasome-induced degradation of the CENP-B
protein. Furthermore they indicate that ICP0 keeps its activity
in mouse cells. However, another protein was detected at a size
of about 110 kDa. The amount of this protein slightly dimin-
ished in HSV-lwt infected cells but did not completely disap-
pear. We would like to propose two hypotheses for the
detection of this 110 kDa protein. The ﬁrst one is a putative
cross reactivity of the anti-CENP-B mAb against an undeter-
mined protein. However, the stability of this protein is alsopartially aﬀected by ICP0. It is excluded that this could be
an unspeciﬁc eﬀect of the infection because this partial degra-
dation is absent in the presence of MG132 and in cells infected
with ICP0-mutant viruses. It is thus striking and highly coinci-
dental that the stability of a protein unspeciﬁcally recognized
by the anti-CENP-B antibody would also be aﬀected by
ICP0. Therefore, a second hypothesis is that at least part of
the pool of the 110 kDa protein would be present in the centro-
meric region targeted by ICP0. In this case, the 110 kDa pro-
tein could well be an undetermined post-translationally
modiﬁed form of cenpB that only partially localizes to the cen-
tral core region of centromeres.
In this study we show that in addition of CENP-A and -C,
the stability of a third centromeric protein, CENP-B, is af-
fected by ICP0. Recent publications described on the basis
of tandem aﬃnity puriﬁcation techniques, as many as 11 new
CENPs, directly or indirectly interacting with the CENP-H-I
662 P. Lomonte, E. Morency / FEBS Letters 581 (2007) 658–662complex and/or the CENP-A-associated nucleosomes [19,20].
In light of these data, we can reasonably speculate that ICP0
would aﬀect the stability of a lot more of these CENPs pro-
vided that they are localized in the immediate vicinity of
ICP0 during the time it resides on the centromere. This gives
ICP0 a major importance as an exceptional tool for studying
the consequences of centromeric destabilization on the cell
physiology. Indeed, no other proteins to date have been found
which possess such an activity on centromere proteins. More-
over, siRNA technique, although helpful to target one protein
or another, is unlikely to be as eﬃcient as ICP0, if multiple
centromeric protein depletion is required.
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